Pegfilgrastim Biosimilars Market is estimated to Witness High Growth Owing to Rising Biosimilar Approvals
Pegfilgrastim biosimilars are medications that stimulate the production of white blood cells (neutrophils) in patients who have received cancer treatment such as chemotherapy. They work similarly to existing biological drugs called filgrastim but with lower costs. The need for pegfilgrastim biosimilars is increasing as they provide an effective and affordable alternative to costly biologic drugs for cancer patients undergoing chemotherapy.
The global pegfilgrastim biosimilars market is estimated to be valued at US$ 1.69 Bn in 2024 and is expected to exhibit a CAGR of 9.8% over the forecast period 2024 to 2031.
Get More Insights On Pegfilgrastim Biosimilars Market
https://www.newsstatix.com...
Pegfilgrastim biosimilars are medications that stimulate the production of white blood cells (neutrophils) in patients who have received cancer treatment such as chemotherapy. They work similarly to existing biological drugs called filgrastim but with lower costs. The need for pegfilgrastim biosimilars is increasing as they provide an effective and affordable alternative to costly biologic drugs for cancer patients undergoing chemotherapy.
The global pegfilgrastim biosimilars market is estimated to be valued at US$ 1.69 Bn in 2024 and is expected to exhibit a CAGR of 9.8% over the forecast period 2024 to 2031.
Get More Insights On Pegfilgrastim Biosimilars Market
https://www.newsstatix.com...
3 months ago
